Lymphedema is a chronic and progressive disease of the lymphatic vessels which affects about 300 million people worldwide. Patients may experience recurrent soft tissue infection of the limb affected by lymphedema, in terms of erysipelas, lymphangitis or cellulitis. No previous study has ever investigated the possible role of the gut microbiota in the genesis of acute infectious/inflammatory episodes in these patients. Our hypothesis is that lymphedema patients with recurrent soft tissue infections are characterized by pro-inflammatory changes in the microbiota.
Study Type
OBSERVATIONAL
Enrollment
60
typing of the gut microbiota from a stool sample
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy
RECRUITINGcomparison alpha diversity
comparison alpha diversity of the gut microbiota in groups A and B
Time frame: 60 months
comparison beta diversity
comparison beta diversity of the gut microbiota in groups A and B
Time frame: 60 months
evaluation of the microbiome differential abundance
evaluation of the microbiome differential abundance to identify taxa associated
Time frame: 60 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.